NDC 70518-2833-09 - Metformin Hydrochloride

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70518-2833
Requested NDC
70518-2833-09
Package NDCs from labels
70518-2833-0, 70518-2833-1, 70518-2833-2, 70518-2833-3, 70518-2833-4, 70518-2833-5, 70518-2833-6, 70518-2833-7, 70518-2833-8, 70518-2833-9, 70518-2833-09
Manufacturer
REMEDYREPACK INC.
Effective date
2026-10-26
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Metformin Hydrochloride - REMEDYREPACK INC.REMEDYREPACK INC.2026-10-26HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
EffectiveRelated label
2022-02-07These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-02-07These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-02-07These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-02-07These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-02-07These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-02-07These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-02-07These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-01-28These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-01-28These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-01-28These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-01-28These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-01-28These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-01-28These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995
2022-01-28These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70518-2833-0Metformin Hydrochloride30 in 1 BLISTER PACKTABLET3020
70518-2833-1Metformin Hydrochloride90 in 1 BOTTLE, PLASTICTABLET9020
70518-2833-2Metformin Hydrochloride180 in 1 BOTTLE, PLASTICTABLET18020
70518-2833-3Metformin Hydrochloride120 in 1 BOTTLE, PLASTICTABLET12020
70518-2833-4Metformin Hydrochloride60 in 1 BLISTER PACKTABLET6020
70518-2833-5Metformin Hydrochloride30 in 1 BLISTER PACKTABLET3020
70518-2833-6Metformin Hydrochloride30 in 1 BOTTLE, PLASTICTABLET3020
70518-2833-7Metformin Hydrochloride100 in 1 BOTTLE, PLASTICTABLET10020
70518-2833-8Metformin Hydrochloride30 in 1 BOTTLE, PLASTICTABLET3020
70518-2833-9Metformin Hydrochloride30 in 1 BLISTER PACKTABLET3020

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-2833METFORMIN HYDROCHLORIDE TABLET [REMEDYREPACK INC.]15Current NDC, Legacy NDC, 10 package rows20250423_30658e19-8e6e-49aa-a007-e414224797c5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 130 · 2,595 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HERA SILKYSTAY FOUNDATION 44C1TITANIUM DIOXIDEAmorepacific Corporation5f42d960-6b86-b4cd-e063-6294a90a98f32026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 45N1TITANIUM DIOXIDEAmorepacific Corporation5f4326fc-b3c3-1a8b-e063-6294a90a8d9b2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 45W1TITANIUM DIOXIDEAmorepacific Corporation5f4335c8-596f-3269-e063-6294a90a6c3d2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 46W1TITANIUM DIOXIDEAmorepacific Corporation5f43404e-bdab-3f4b-e063-6294a90ab8812026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 47N1TITANIUM DIOXIDEAmorepacific Corporation5f435148-dcb1-cfdf-e063-6394a90aa8b62026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 50N1TITANIUM DIOXIDEAmorepacific Corporation5f43610f-6c4f-dd9d-e063-6394a90ab60a2026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 48N1TITANIUM DIOXIDEAmorepacific Corporation5f4372c4-b87a-91ab-e063-6294a90a68072026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 49C1TITANIUM DIOXIDEAmorepacific Corporation5f4380d1-2cf4-1fd8-e063-6394a90a0aa32026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA BLACK CUSHION FOUNDATION 13N1OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDEAmorepacific Corporation5aff3d25-d034-0815-e063-6294a90a86642026-10-29WarningsExact identifier
unii: 15FIX9V2JP
Blue Lizard Sensitive SPF 50 SunscreenTITANIUM DIOXIDE AND ZINC OXIDECrown Laboratories32d78048-d281-1d80-e063-6394a90aec192026-10-28WarningsExact identifier
unii: 15FIX9V2JP
METFORMIN HYDROCHLORIDEMETFORMIN HYDROCHLORIDENuCare Pharmaceuticcals,Inc.55062171-7581-0630-e063-6394a90ac0882026-10-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861007
unii: 786Z46389E
HERA SILKYSTAY FOUNDATION 32W1TITANIUM DIOXIDEAmorepacific Corporation5eed2165-afc2-6958-e063-6294a90add582026-10-28WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 34O1TITANIUM DIOXIDEAmorepacific Corporation5eedd87b-a7b1-1abc-e063-6294a90ae29e2026-10-28WarningsExact identifier
unii: 15FIX9V2JP
Metformin HydrochlorideMETFORMIN HYDROCHLORIDEMicro Labs Limitedcc070735-5e8d-4bb3-9caa-e84d29bb89432026-10-27Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 786Z46389E
Metformin HydrochlorideMETFORMIN HYDROCHLORIDEREMEDYREPACK INC.55b25f66-a0a3-4e2e-9c4a-6354f41072fa2026-10-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861004
unii: 786Z46389E
Metformin HydrochlorideMETFORMIN HYDROCHLORIDEREMEDYREPACK INC.30658e19-8e6e-49aa-a007-e414224797c52026-10-26Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA090564
ndc (package): 70518-2833-5
ndc (package): 70518-2833-9
ndc (package): 70518-2833-6
ndc (package): 70518-2833-1
ndc (package): 70518-2833-3
ndc (package): 70518-2833-7
ndc (package): 70518-2833-2
ndc (package): 70518-2833-8
ndc (package): 70518-2833-4
ndc (package): 70518-2833-0
ndc (product): 70518-2833
ndc11 (package): 70518283309
rxcui: 861007
spl id: 5ebdcc21-9da4-a52c-e063-6294a90a4cd8
spl set id: 30658e19-8e6e-49aa-a007-e414224797c5
unii: 786Z46389E
Metformin HydrochlorideMETFORMIN HYDROCHLORIDENuCare Pharmaceuticals, Inc.583f2a2e-a9d7-f266-e063-6294a90ad0ab2026-10-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861004
unii: 786Z46389E
HERA SILKYSTAY FOUNDATION 26N1TITANIUM DIOXIDEAmorepacific Corporation5ec7151e-4f83-4aca-e063-6294a90a98182026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 26W1TITANIUM DIOXIDEAmorepacific Corporation5ec7276d-fcaf-65b2-e063-6394a90ac2202026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28C1TITANIUM DIOXIDEAmorepacific Corporation5ec73566-5d67-7153-e063-6394a90aba332026-10-26WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.